well known in rats fed similar diets, and that the sample size (six rats) was too small to draw any conclusions.
I
n the 5 yr since the first large-scale commercial harronmental Protection Agency (USEPA), and the U.S. vest, the area planted to transgenic crops in the U.S.
Department of Agriculture's (USDA) Animal and Plant has grown to more than 28.4 million ha (more than 71
Health Inspection Service (APHIS) all have jurisdiction million acres) in 1999, where approximately 35% of all for monitoring and regulating the development, testing, corn (Zea mays L.) and 55% of all soybean [Glycine and release of GM plants and plant products. max (L.) Merr.] planted were transgenic (James, 1999) .
The Federal Food, Drug, and Cosmetic Act grants Because soybean and corn are used as ingredients in a the FDA authority to regulate commercialization and wide range of food products, many foods on grocery marketing of most domestic and imported foods in the store shelves currently contain ingredients derived from U.S. market. Under the 1992 Policy interpretation (USgenetically engineered crops. Barring a consumer back-FDA, 1992), GM foods and food ingredients must comlash, the area planted to transgenic crops will continue ply with the same standards that apply to other food to rise, resulting in ever more foods derived from transproducts. This means that GM foods must be as safe genic crops (GM foods) in the marketplace.
and nutritious as their non-GM counterparts in grocery Throughout the development and commercialization stores today. The Act places legal duty on developers of transgenic crops, health and food safety concerns to ensure that the foods they market to consumers are have been raised and regulatory procedures established safe to eat. Transgenic crops containing novel proteins to ensure the safety of GM foods. The main concerns classified as food additives are subjected to additional voiced have been questions about the potential of GM testing and must receive premarket approval by the crops to:
FDA before commercialization, while whole foods made from transgenic crops passing GRAS (generally • Inadvertently introduce toxins recognized as safe) standards are subject to FDA regula-• Introduce allergens tion after commercialization. The FDA has the broad • Change the levels of essential nutrients, and/or authority to take legal action against developers of any • Compromise antibiotic therapies food or food additive that poses a hazard to the public. Issues of food safety from GM crops came to the fore The FDA published its 1992 policy to assist developwith a report that a greater number of laboratory rats ers in addressing food safety and regulatory issues be-(Rattus rattus) suffered from abnormalities in their small fore products reach the market. The policy statement intestines after 10 d of feeding on GM potato diets contains a comprehensive "guidance to industry" sec-(Solanum tuberosum L.), relative to those feeding on tion that discusses scientific issues for assuring food non-GM potato diets (Ewen and Pusztai, 1999) . In an safety and identifies scientific and regulatory questions extraordinarily unusual step within the scientific field, that developers must consider to determine if they the same journal that published the paper simultaneshould consult with the FDA before commercial release ously published the rebuttal (Kuiper et al., 1999 
Changes in Essential Nutrients Inadvertent Synthesis or Increase in Toxins
Certain crop plants are major suppliers of essential nutrients to the human diet. For example citrus crops Many plants produce a number of toxins and antinuare major sources of vitamin C, carrot (Daucus carota tritional factors that are thought to provide resistance L.) is a source of vitamin A, and grain legumes are a to natural herbivores (Kessler et al., 1992) . In most source of protein and essential amino acids. Under FDA domesticated crop species, the concentrations of such policy, developers of new food crop varieties, including toxins are so low that they present no health concerns.
GM crops, must determine that levels of essential nutriIn other species (e.g., potato), breeders routinely screen ents in the new variety are not significantly different new varieties to make sure that toxins are within a safe from levels traditionally associated with those crops. If, limit. In some crop species (e.g., cassava, Manihot escuafter reveiw of results from tests, levels of essential lenta Crantz), the food product must be cooked or pronutrients are found to be significantly different in the cessed to inactivate toxic substances. In GM crop plants, new crop, the FDA has the authority to disallow comtoxins are of concern in any species in which unsafe mercialization of the crop, or require that foods derived levels have been found in its lines, varieties or relatives, from the crop be labeled to inform the consumer of the or if transgenes are derived from such species. In those altered nutrient content. cases, developers of GM crops must determine that toxGenetically modified crops are being developed with ins are absent, or present within a safe range, before enhanced nutritional qualities, such as increased iron commercialization of the crop. In addition, a number or vitamin A content in edible plant parts (Goto et al., of groups of proteins present in common foods are toxic 1999; Ye et al., 2000) . In such cases, the transgenic crop or antinutritional. Development of GM crop plants with could be subject to a full food safety evaluation before gene sequences encoding such proteins is not recomapproval for commercialization and to labeling requiremended, and if developed, such varieties would be subments following commercialization (USFDA, 1992). ject to a full food safety review.
A recent paper by Lappé et al. (1998) reported that Another concern is the potential for silent toxin path-GM soybean had lower levels of isoflavones, considered ways to be reactivated in GM crops due to the genetic important for human health, than non-GM soybean, engineering process. Plants, like other organisms, have which allegedly demonstrates the inadequacy of the curmetabolic pathways that no longer function due to mutarent regulatory system. The American Soybean Associations that occurred during evolution. Products or intertion promptly reacted by providing documentation that mediates from some of these pathways may be toxins. the changes observed by Lappé et al. (1998) were well Questions have been raised as to the potential for gewithin the normal range of isoflavone concentrations netic engineering to reactivate those pathways. Howfor soybean (ASA, 1999) . ever, a determination was made that the likelihood of such events occurring in food plants with a long history
Introduction of Allergens
of safe use is remote, and that the potential would likely have been detected during breeding evaluations of the Food allergies occur in Ͻ1 to 2% of the population, crop and its use for food (reviewed in Kessler et al., and most sufferers have been shown to be allergic to 1992). Currently, all transgenic food crops approved only a few specific proteins in one or two specific foods for commercialization in the USA (e.g., corn, soybean, (reviewed in Hefle et al., 1996; Metcalfe et al., 1996) . potato, etc.) have long histories of breeding and use as Eight foods (peanut [Arachis hypogaea L.], soybean, foods, and this history can be used to evaluate potential tree nuts, milk, eggs, fish, crustaceans, and wheat [Tritifor toxin production. Transgenic crops that have breedcum aestivum L.]) account for Ͼ90% of food allergies ing and/or food use histories that indicate a potential worldwide (reviewed in Metcalfe et al., 1996 ; Taylor for toxin production are subject to a full food safety and . Food allergies are of major concern, evaluation prior to commercialization. Similar safety as people with allergies to those foods can exhibit reacevaluations would be necessary for new crops lacking tions that are sudden, severe, and life-threatening (rea long history of breeding and use in food, since the viewed in Taylor and Lehrer, 1996) . potential for toxin production would be difficult to preGuidelines for assessing the allergenic potential of GM crops were established by the FDA following extendict in these crops. sive review of research on food allergies and consultament or in the gut of humans or animals would tion with leading researchers in the areas of food safety, compromise antibiotic therapy by rendering pathogens food allergies, immunology, biotechnology, and diagimmune to the effects of the antibiotic. Accordingly, nostics (USFDA, 1994 of GM crops and food products containing antibiotic All known food allergens are proteins, many of which resistance transgenes, by addressing: share several features: amino acid sequence similarity
• The potential toxicity of the protein encoded by to each other, molecular weight between 10 and 70 kDa, the antibiotic resistance gene glycosylation, acidic isoelectric points, and resistance to
• The potential for the protein to elicit allergenic reheat, acid treatment, proteolysis, and digestion (reactions viewed in Lehrer et al., 1996; Taylor and Lehrer, 1996) .
• The importance of the antibiotic as a medication Nevertheless, exceptions exist. Therefore, to ensure that
• The frequency of use of the antibiotic new GM crops do not contain a new allergen, its aller-
• Whether the antibiotic is orally administered genic potential must be assessed based on:
• The uniqueness of the antibiotic • The gene source (did it come from a species known
• The potential for transfer of the antibiotic resisto cause food allergy?) tance transgene from plants to microorganisms, and • The crop to be engineered (do foods derived from whether such a transfer would enhance the survival that crop cause food allergies?) of the microorganisms that incorporated the antibi-• The gene and protein sequence (does it share traits otic resistance gene with known allergens?)
• The frequency of antibiotic resistance naturally found in bacterial populations To aid in evaluation of those criteria, a decision tree strategy was formulated (Metcalfe et al., 1996) . If the These guidelines were established following consultaanswer is yes to any of the questions posed in the diation with experts in the fields of microbiology, medicine, gram, specific tests and assays are recommended. If bacterial and mycotic diseases, and food safety. Addiallergenic potential is indicated, the FDA will require tional confirmation of the guidelines' ability to ensure labeling to inform consumers of the allergenic potential, that GM crops containing antibiotic resistance transor to take legal action against commercialization.
genes are safe was provided by national and internaTo illustrate how the regulatory system works, Piotional food safety regulatory agencies including the neer Hi-Bred International scientists introduced a gene USEPA, the European Commission Scientific Commitfrom the Brazil nut (Bertholletia excelsa Humb. & tees for Food and Animal Nutrition, the Nordic WorkBonpl.) into soybean to improve the methionine content ing Group on Food Toxicology and Risk Assessment, of the protein. Because allergic reactions to Brazil nut and the World Health Organization/Food and Agriculhad been previously documented, skin prick tests, inhiture Organization (ECSCF, 1996; Karenlampki, 1996; bition immunoassays, and immunoblotting were recom-USEPA, 1994; WHO, 1993 WHO, , 1996 . mended for testing the allergenic potential of the Brazil
The antibiotic resistance transgene used to develop nut protein engineered into soybean. During the rethe GM crop plants currently in the market is the NPTII quired evaluation process, the protein made by the inor APH(3Ј)II gene, which provides resistance to the troduced gene was found to be allergenic (Nordlee et antibiotics kanamycin and neomycin by detoxifying al., 1996), and Pioneer announced it was discontinuing them (reviewed in Flavell et al., 1992) . A detailed dethe work with the Brazil nut gene.
scription of the safety assessment of the NPTII gene and its protein product is provided by Calgene (1990) , by USFDA (1994) and in the USFDA Guidance to
Reduced Efficacy of Antibiotics

Industry: Use of Antibiotic Resistance Marker Genes in Genetic engineering of plant cells is an inefficient
Transgenic Plants (1998) . In accordance with the criteria process, and only a very small percentage of the cells listed earlier, the NPTII gene was deemed safe for use targeted for DNA delivery actually integrate and ex- (Calgene, 1990; reviewed in Flavell et al., 1992) based press the new transgenes. To isolate the transgenic cells on the following: from the millions of nontransgenic cells in a tissue, scien-
• No evidence of allergenicity or toxicity could be tists usually link what is known as a selectable marker identified. gene, usually a gene encoding for antibiotic resistance
• Kanamycin-resistant bacteria are so common in nato the transgene(s) of interest. Cells are then grown in ture that the average human eats 1.2 million bactea laboratory culture medium containing the antibiotic. ria containing the NPTII gene each day, primarily Only those cells that have integrated the antibiotic resison fresh vegetables. tance transgene live and grow into plants.
• Eating food containing NPTII would not comproEarly in the development of transgenic crops, a conmise the oral use of kanamycin in humans because cern was raised that the transfer of the antibiotic resistance transgene from plants to pathogens in the environthe protein is rapidly inactivated and degraded in the gut. Also, NPTII requires ATP to function, and evaluation of scientific data from several disciplines related to genetic engineering and food safety, and consul-ATP is present in only extremely low concentrations in the digestive system. tation with experts from around the world, the FDA has established guidelines for the safe commercial intro-• The transfer of the NPTII gene from plants to pathogenic bacteria was highly unlikely to occur, duction of food from GM crops. Any such foods that meet FDA guidelines are deemed to be as safe as other and even if it did, would not increase the amount of kanamycin-resistant bacteria. Each human gut foods on the market. Food safety guidelines established using current scientific knowledge are not static, and naturally contains 10 12 kanamycin-resistant bacteria. The worst-case scenario is that eating a tomato will continue to be refined as new knowledge is gained in areas related to food safety. For those interested in (Lycopersicon esculentum Mill.) with the NPTII gene would increase the frequency of kanamycinlearning more about safety assessment of GM foods, the following Web sites are suggested as excellent starting resistant bacteria in the gut by 0.000001%. points for obtaining further information and references: Similar data were presented to demonstrate the safety of the NPTII gene in animal feed and in exposure of soil http://www.aphis.usda.gov/ USDA Biotechnology biotechnology page microorganisms to GM crops in large-scale production scenarios (USFDA, 1998 safe (USFDA, 1998) . Calgene. 1990 . Request for advisory opinion-kan gene: Safety and use in the production of genetically engineered plants. FDA Docket The conclusion that the NPTII and the ampicillin Rockville, MD. resistance genes are safe to use in GM crops has also Ebinuma, H., K. Sugita, E. Matsunaga, and M. Yamakado. 1997. been reached by other scientific panels and regulatory Selection of marker-free transgenic plants using the isopentenyl agencies (USEPA, 1994; Karenlampi, 1996 ; ECSCF,
Genetically Modified Crops and the Environment
Joanne E. Barton and Miles Dracup* ABSTRACT is also the opportunity to grow crops with industrial, neutraceutical (functional foods), and pharmaceutical (Brill, 1985; Colwell et al., 1985; Boulter, 1993 ; Harconsiderable, often polarized debate. This review seeks a balanced lander, 1990; Hileman, 1995; Lewis and Palevitz, 1999;  appraisal of environmental issues, and looks at principles associated Miflin, 1999; Nottingham, 1998; Porter, 1999 security (Rural Advancement Foundation Int., 1999) .
The environmental sustainability of using GMOs will depend largely
The effects of GM corn pollen on larval development on wise management practices and monitoring must provide approof the monarch butterfly (Losey et al., 1999) and the priate data to support continuing adaptation of management and premature release of feeding trial data during GM prodregulation of GMOs.
uct development have generated negative public opinion often associated with press coverage of technological controversy (Gaskell et al., 1999; Royal Society, 1999) .
T he use of molecular biological techniques to manipSuspicion of the intentions of corporate players (Vidal, ulate DNA and thus alter the make-up of organisms 1999) has been exacerbated by the provision of inaccuhas provided alternative strategies for on-farm managerate information to regulators (Coghlan, 1999 ; Woolf, ment of weeds, pests, and disease (James, 1998). There 1999) and proposals to control seed viability (Oliver et al., 1998 asses the environmental benefits resulting from the in-
